#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Sandy Lewis Email
Executive Director, Biostatistics: Head Biometrics . Chinook Therapeutics
Vancouver, BC
LocationPrimary Email
How to contact Sandy Lewis
Join and see Sandy's contact info for free!Current Roles
Employees:
264Revenue:
$1.2MAbout
Chinook Therapeutics is a biotechnology company developing precision medicines for patients with kidney diseases. We apply our proprietary research platform to discover and develop therapeutics with novel mechanisms of action against key kidney disease pathways. The development focus is on rare, serious disorders with clear unmet medical needs and defined and rapid clinical development opportunities. Chinook recently in-licensed a late-stage product, atrasentan, and plans to initiate a phase 3 trial for chronic kidney disease by the first half of 2021. Our pipeline has several other internal programs at the validation and lead optimization stages, the first of which is rapidly progressing to enter clinical trials by 2021. We are also evaluating business development opportunities for early and late-stage clinical assets to enhance the pipeline. Chinook has raised a $65 million Series A financing from top tier venture capital firms Versant Ventures, Apple Tree Partners, and Samsara BioCapital. We are a growing team of approximately 40 employees and are based in Vancouver, British Columbia and Seattle, Washington.Chinook Therapeutics Address
210-887 Great Northern WayVancouver, BC
CAN